A Study of Flt3-Ligand Levels in Sjögrens Syndrome
NCT01470638 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2019-04-24
Summary
The study aims to correlate levels of Flt3-ligand in Cerebrospinal Fluid (CSF) and serum to markers for inflammation and degeneration in patients with primary Sjogrens syndrome.
Conditions
- Sjogrens Syndrome
Sponsors & Collaborators
-
Göteborg University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-06-30
- Primary Completion
- 2019-04-30
- Completion
- 2019-04-30
Countries
- Sweden
Study Locations
More Related Trials
-
Platelet and Red Blood Cell Volume Indices as Inflammatory Biomarkers in Ankylosing Spondylitis
NCT05997108 ·Status: UNKNOWN
-
Expression of CXCR4 in Patients With Systemic Lupus Erythematosus
NCT04799730 ·Status: UNKNOWN
-
Flow Mediated Dilation in Association With Hyperuricemia
NCT05342285 ·Status: UNKNOWN
-
Association of Serum Interleukin-33 Levels With Clinical Manifestations in Systemic Lupus Erythematosus
NCT07149402 ·Status: NOT_YET_RECRUITING
-
Microvascular Ocular Changes of Systemic Lupus Erythematous
NCT05863689 ·Status: RECRUITING
-
Anti-CD20 Antibody Therapy for Sjogren's Syndrome
NCT00101829 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Leukocyte Populations in Patients With Chronic Inflammatory
NCT04749875 ·Status: NOT_YET_RECRUITING
-
Study of Iguratimod in Sjögren's Syndrome
NCT03023592 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease
NCT07041099 ·Status: RECRUITING ·Phase: PHASE1
-
Autotaxin as Abiomarker in Systemic Lupus Erythematosus Patients
NCT06063668 ·Status: NOT_YET_RECRUITING
-
Clinical Performance of BioCLIA Ro60
NCT03204448 ·Status: WITHDRAWN
-
Comparison of Clinical Effects of Azathioprine and Rituximab NMO-SD Patients
NCT03002038 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study of RSLV-132 in Females With Sjögren's Disease
NCT06440525 ·Status: RECRUITING ·Phase: PHASE2
-
Tear Proteins, Conjunctival Cells and Imaging Eyes in Rheumatoid Arthritis and Systemic Lupus Erythematosus Patients
NCT02217137 ·Status: COMPLETED
-
NFC Changes in SLE Patients and Its Correlation With Anti-U1RNPAntibodies and Disease Activity
NCT05106998 ·Status: UNKNOWN
-
Ro60 Expression in Macrophages in Sjogren's Disease
NCT06324968 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Libman-Sacks Endocarditis as a Cause of Neuropsychiatric Systemic Lupus Erythematosus
NCT00858884 ·Status: WITHDRAWN ·Phase: NA
-
Biomarkers of Lupus Disease: Serial Biomarker Sampling in Patients With Active Systemic Lupus Erythematosus (SLE)
NCT00987831 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Renal Assessment for Early Detection of Renal Impairment in Systemic Sclerosis and Systemic Lupus Erythematosus Patients
NCT06287125 ·Status: NOT_YET_RECRUITING
-
Prevalence of Pre-clinical Sjögren Disease and Other Immune Disturbances in Subjects With Autoimmune Thyroiditis Disease
NCT06324578 ·Status: RECRUITING
-
Serum Ceramides Level in Systemic Lupus Erythematosus (SLE) Patients as a Novel Marker for Renal Impairment
NCT04256577 ·Status: UNKNOWN
-
A Study to Evaluate the Efficacy and Safety of Telitacicept in Subjects With Active Primary Sjogren's Syndrome
NCT05673993 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis
NCT04186871 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison Between Early-onset and Late-onset Patients With Systemic Lupus Erythematosus.
NCT06294483 ·Status: ENROLLING_BY_INVITATION
-
Cardiac and Laboratory Findings in Patients With Systemic Lupus Erythematosus
NCT03179046 ·Status: COMPLETED